Ms. Louise Mcintyre Toves, M.A., CSAC III, LPC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 790 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-475-5440 |
Kendra Taylor Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 790 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-685-7012 |
Ms. Leinani Matsue Quintanilla Naholowaa, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1244 N Marine Corps Dr, Tamuning, GU 96913 Phone: 671-647-8262 |
Beverly Grace Delos Reyes, M.A., L.P.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 790 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-647-5440 |
Ms. Valerie K Reyes, MA,IMFT,ICADC, CSAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1244 N Marine Corps Dr, Suite 101, Tamuning, GU 96913 Phone: 671-647-8262 |
Andrea Ada, ACSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 790 Governor Carlos Camacho Road, Tamuning, GU 96913 Phone: 671-647-2057 |
Miss Rethelje Ann Finona, M.A. LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 790 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-647-5447 |
Ms. Julie Jones Murrell, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 470 N Marine Corps Dr, Tamuning, GU 96913 Phone: 671-687-8581 |
Chi Man Santos, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 388 Ypao Rd, Tamuning, GU 96913 Phone: 671-646-8881 |
Mr. Jesse Unsiog Baleto, MSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1244 N Marine Corps Dr, Suite 101, Tamuning, GU 96913 Phone: 671-647-8262 Fax: 671-647-8257 |
Mr. Tony Salas Cruz Jr., M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 790 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-647-5732 |
Mc Jason Frias De Luna, LPC-178 Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 790 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-647-2056 |
Ovita Perez Counselor Medicare: Not Enrolled in Medicare Practice Location: 790 Governor Carlos Camacho Street, Tamuning, GU 96913 Phone: 671-477-5338 Fax: 671-477-5330 |
Frances Munoz, M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 790 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-647-5440 |
Mrs. Maria Teresa Pereda Aguon, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 790 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-647-5351 Fax: 671-647-5414 |
News Archive
Alma Lasers Ltd., a global leader in aesthetic laser, light-based, and radiofrequency systems, announces important developments in its patent dispute with Lumenis Ltd., which is being litigated in the United States District Court in Chicago, IL. Alma reports that: (1) the U.S. Patent and Trademark Office in Alexandria VA ("PTO") has decided to reexamine all seven of Lumenis's patents that are at issue in the litigation, and (2) the Court has stayed the litigation, pending reexamination of the patents.
QAD Inc., a leading provider of enterprise software and services for global manufacturing companies, announced today that Aberdeen Group, a leading firm of technology analysts, has published QAD On Demand Gives Manufacturers the Tools They Need to Become Global - its latest Analyst Insight report - in which it cites QAD as a pioneer in delivering a complete Enterprise Resource Planning (ERP) solution in a Software as a Service (SaaS) delivery model.
Perfusion CT scanning, an emerging imaging technology, got a bad rap last year when a machine set to incorrect radiation levels overdosed hundreds of people in Los Angeles. In the wake of this incident, researchers at the Mayo Clinic, excited by the technology's promise for diagnosing stroke, cancer, and possibly heart disease, have developed a way to reduce the amount of radiation involved in the procedure - which, when done properly, already involves very little risk.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
› Verified 3 days ago